NVNO - צמיחת הכנסות ב-12 חודשים נגררים enVVeno Corp

enVVeno Medical (NVNO) faces margin pressure due to its reliance on Asian component imports amid ongoing trade conflicts. The year-over-year sales volume growth trajectory over a rolling year, with the current level sitting around 0.00, links these risks to the necessity of sterile implant delivery to clinics. Meanwhile, the lack of stable cash flow leaves the company vulnerable until it secures FDA approval.
envveno.com (NVNO) - פילוחי מדדים ודוחות פיננסיים

Efficient logistics for high-precision venous valve components directly impact the annual sales growth rate for enVVeno Medical (NVNO) on an LTM basis. This indicator captures the percentage change in revenue over a rolling twelve-month period, determining the business expansion vector. The TTM calculation method eliminates gaps between reports, ensuring data relevance. The current value of 0.00 reflects market demand dynamics. Investors should compare this growth with profitability to rule out hidden loss-making scaling.